Rethinking ALT Recent developments have intimated a reassessment of of share price potential. Current price targets in my estimation DO NOT REFLECT A PROBABLE LIKELY SCENARIO. It has very recently discussed there may be a need for ANNUAL COVID VACCINATIONS FOREVER. Which means Alt may not be late to the party. They will overtake Pfizer, Moderna, and possibly even Novavax. If the vaccine shows efficacy, they will be the hands down biggest global player. No need for refrigeration is HUGE. Only one dose needed and a reasonable shelf life.
Market Data 
Markets 
AI
